OpenAlex
PricingAboutJobs
Log inGet started
Work

Early molecular response and female sex strongly predict stable undetectable BCR-ABL1, the criteria for imatinib discontinuation in patients with CML

HTML

Year: 2013
Type: article
Source: Blood
DOI: 10.1182/blood-2012-10-462291
Authors: Susan Branford, David T. Yeung, David M. Ross, Jodi A. Prime, Chani R. Field, Haley K. Altamura, Alexandra L. Yeoman, Jasmina Georgievski, Bronte A. Jamison, Stuart Phillis, Brad Sullivan, Nancy E. Briggs, Mark Hertzberg, John F. Seymour, John Reynolds, Timothy P. Hughes
Institutions: South Australia Pathology, Centre for Cancer Biology, The University of Adelaide, Flinders University, The University of Sydney, Westmead Hospital, Australasian Leukaemia and Lymphoma Group, The University of Melbourne, Peter MacCallum Cancer Centre, Deakin University
Language: English

Topic: Chronic Myeloid Leukemia Treatments
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Keywords: chronic myeloid leukemia, imatinib discontinuation, BCR-ABL1, major molecular response, early molecular response, female sex, predictive factors
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2030615871
FWCI: 13.81
Cites: 45
Cited by: 186
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms